description

Four large drug companies reached a last-minute, $260 million legal settlement over their role in the U.S. opioid addiction epidemic, averting the first federal trial that was scheduled to start Monday morning in Cleveland. Jillian Kitchener has more.

general info

  • Uploaded    10/21/2019
  • Business & Finance
  • Bon appetit! French restaurants re-open
  • Polestar ramps up battle with Tesla in China
  • Stocks have more room to run: analyst
  • Recovery hopes lift Wall Street
  • German coalition parties wrestle over fiscal stimulus package
  • Southwest offers buyouts to 'ensure survival'
  • Music industry lends its voice to Blackout Tuesday protest
  • California oyster farmer confident in industry's return
  • Gilead is developing inhaled remdesivir